CNCE
Concert Pharmaceuticals, Inc.
CNCE
CNCE
Delisted
CNCE was delisted on the 3rd of March, 2023.
53 hedge funds and large institutions have $58M invested in Concert Pharmaceuticals, Inc. in 2022 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 7 increasing their positions, 24 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
less call options, than puts
Call options by funds: $ | Put options by funds: $
71% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 24
Holders
53
Holding in Top 10
–
Calls
$54K
Puts
$56K
Top Buyers
| 1 | +$1.27M | |
| 2 | +$215K | |
| 3 | +$80K | |
| 4 |
Jane Street
New York
|
+$56K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$52K |
Top Sellers
| 1 | -$1.13M | |
| 2 | -$708K | |
| 3 | -$504K | |
| 4 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$372K |
| 5 |
Millennium Management
New York
|
-$350K |